RAIZ DIAGNOSTICS, INC.
Scaling Lymphoma Diagnosis: A Cost-Effective Gene Expression Assay for Broad Implementation
Scaling Lymphoma Diagnosis: A Cost-Effective Gene Expression Assay for Broad Implementation is a funding opportunity from RAIZ DIAGNOSTICS, INC., up to 1770000, closing August 31, 2027.
Aug 31, 2027
(396d left)Overview
Abstract Lymphoma is a potentially curable cancer, yet timely and accurate diagnosis remains a significant barrier to care, particularly in hospitals outside of metropolitan centers that lack consistent access to expert hematopathologists. Standard diagnosis involves iterative immunohistochemistry and complex…